Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
RAINBOW
company
About
RAINBOW was established with the aim of promoting the development of autologous bone marrow mesenchymal stem cell products
- 1 - 10
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- ¥150M
- Industries
- Health Care,Medical
- Founded date
- Aug 9, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥150M
RAINBOW has raised a total of
¥150M
in funding over 2 rounds. Their latest funding was raised on
Oct 26, 2020 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 26, 2020 | Seed | ¥150M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
RAINBOW is funded by 2 investors.
Hokkaido Research Institute for the Twenty-first Century
and Okasan Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Hokkaido Research Institute for the Twenty-first Century
|
— | Seed |
Okasan Capital Partners
|
— | Seed |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
